Literature DB >> 2418309

Mechanism of the vasodilator effects of the cardiotonic agent DPI 201-106.

R P Hof, A Hof.   

Abstract

DPI 201-106 (DP) is a new cardiotonic agent. In experiment on cats anaesthetized with chloralose/urethane, it lowered blood pressure and caused peripheral vasodilatation at doses between 0.3 and 3 mg/kg, infused i.v. Furthermore, DPI lowered heart rate and increased coronary blood flow (measured with tracer microspheres). The mechanism of this vasodilator action was investigated in experiments in vitro using rabbit aorta. DPI inhibited depolarization-induced contraction. The effect was strongly dependent on the contact time. The pIC50 (-log IC50) values for 15 min, 1, and 2 h pretreatment were 4, 5.2, and 5.7, respectively. 45Ca2+ uptake into rabbit aorta was inhibited by DPI with pIC50 values of 4.3, 5.1, and 5.7, respectively, for the pretreatment periods indicated above. The excellent agreement between effects on tension development and calcium uptake suggests that the mechanism of vasodilatation observed in vivo is related to calcium antagonism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2418309     DOI: 10.1097/00005344-198511000-00028

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

Review 1.  New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan.

Authors:  R E Weishaar; D Kobylarz-Singer; B A Klinkefus
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

2.  The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects.

Authors:  P C Rüegg; E Nüesch
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

3.  The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.

Authors:  Sung-Han Hsiao; Megumi Murakami; Ni Yeh; Yan-Qing Li; Tai-Ho Hung; Yu-Shan Wu; Suresh V Ambudkar; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2018-07-18       Impact factor: 8.679

4.  Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes.

Authors:  H Glossmann; C Zech; J Striessnig; R Staudinger; L Hall; R Greenberg; B I Armah
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

5.  Inotropic and electrophysiological effects of BDF 9148, a congener of DPI 201-106, in guinea-pig atria and papillary muscles.

Authors:  H Brasch; H Iven
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

6.  Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.

Authors:  D Baumgart; T Ehring; M Krajcar; A Skyschally; G Heusch
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

7.  Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.

Authors:  P K Siegl; M L Garcia; V F King; A L Scott; G Morgan; G J Kaczorowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

8.  Mechanisms of positive inotropic effects and delayed relaxation produced by DPI 201-106 in mammalian working myocardium: effects on intracellular calcium handling.

Authors:  Y Kihara; J K Gwathmey; W Grossman; J P Morgan
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.